|
|
|
All News |
| May 19, 2008 |
|
| HyperMed, Inc. Receives Additional $4 Million from GBP Capital |
|
|
Burlington, MA – May 19, 2008 – HyperMed, Inc., the leader in hyperspectral medical imaging, today announces it completed $4 million financing from GBP Capital (GBP) this month. Proceeds will support ongoing marketing and sales of OxyVu™, its lead product.
Mark Carbeau Read More... |
|
| Filed Under: Company News |
| Apr 21, 2008 |
|
| Mark B. Carbeau Appointed Director, Chief Executive Officer and President of HyperMed, Inc, Daniel J. Levangie To Serve as Chairman of the Board of Directors |
|
|
Burlington, MA – April 21, 2008 – HyperMed, Inc., the developer and manufacturer of hyperspectral diagnostic systems with application in diabetic and vascular disease, today announces the appointment of Mark B. Carbeau as Director, Chief Executive Officer, and President, effective Read More... |
|
| Filed Under: Company News |
| Feb 13, 2008 |
|
| Lentigen to Move Headquarters and Manufacturing to Gaithersburg |
|
|
Gaithersburg, MD (February 13, 2008) –
Lentigen Corporation today announced the company is moving its corporate headquarters and manufacturing facilities from the University of Maryland Baltimore County TechCenter to a new 26,000 square-foot facility in Gaithersburg.
Read More... |
|
| Filed Under: Company News |
57 results: <<123456>> |
|
|
|
|
